# Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET

> **NCT01224873** · — · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 110 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01224873
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2013-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01224873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01224873, "Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01224873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*